AllianceBernstein’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $480K | Sell |
35,040
-35,377
| -50% | -$485K | ﹤0.01% | 2661 |
|
|
2025
Q1 | $779K | Sell |
70,417
-128,842
| -65% | -$1.42M | ﹤0.01% | 2359 |
|
|
2024
Q4 | $2.12M | Buy |
199,259
+175,859
| +752% | +$1.87M | ﹤0.01% | 1928 |
|
|
2024
Q3 | $297K | Sell |
23,400
-10,830
| -32% | -$138K | ﹤0.01% | 2924 |
|
|
2024
Q2 | $574K | Buy |
+34,230
| New | +$574K | ﹤0.01% | 2599 |
|
|
2022
Q2 | – | Sell |
-24,500
| Closed | -$213K | – | 3372 |
|
|
2022
Q1 | $213K | Hold |
24,500
| – | – | ﹤0.01% | 2968 |
|
|
2021
Q4 | $233K | Hold |
24,500
| – | – | ﹤0.01% | 3009 |
|
|
2021
Q3 | $412K | Hold |
24,500
| – | – | ﹤0.01% | 2825 |
|
|
2021
Q2 | $374K | Buy |
24,500
+2,600
| +12% | +$39.7K | ﹤0.01% | 2922 |
|
|
2021
Q1 | $427K | Hold |
21,900
| – | – | ﹤0.01% | 2719 |
|
|
2020
Q4 | $395K | Hold |
21,900
| – | – | ﹤0.01% | 2696 |
|
|
2020
Q3 | $422K | Hold |
21,900
| – | – | ﹤0.01% | 2606 |
|
|
2020
Q2 | $572K | Hold |
21,900
| – | – | ﹤0.01% | 2507 |
|
|
2020
Q1 | $391K | Hold |
21,900
| – | – | ﹤0.01% | 2470 |
|
|
2019
Q4 | $731K | Hold |
21,900
| – | – | ﹤0.01% | 2398 |
|
|
2019
Q3 | $522K | Hold |
21,900
| – | – | ﹤0.01% | 2515 |
|
|
2019
Q2 | $787K | Buy |
+21,900
| New | +$787K | ﹤0.01% | 2410 |
|